Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-28

Clinical Trial Update: Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 trial comparing once-daily (OD) versus as-needed (PRN) dosing of vardenafil for erectile dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levitra (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction | Phase 2 | Status: COMPLETED